Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

6.3%

5 terminated/withdrawn out of 79 trials

Success Rate

93.1%

+6.5% vs industry average

Late-Stage Pipeline

41%

32 trials in Phase 3/4

Results Transparency

7%

5 of 67 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A
20(34.5%)
Phase 4
18(31.0%)
Phase 3
14(24.1%)
Phase 2
6(10.3%)
58Total
N/A(20)
Phase 4(18)
Phase 3(14)
Phase 2(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (79)

Showing 20 of 79 trials
NCT07852689Not ApplicableNot Yet Recruiting

Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention Strategies

Role: collaborator

NCT07363161Not ApplicableRecruiting

BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)

Role: lead

NCT02460042Completed

Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW)

Role: lead

NCT04470934Active Not Recruiting

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)

Role: lead

NCT05846893Not ApplicableActive Not Recruiting

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease

Role: collaborator

NCT03809715Completed

Coroflex ISAR NEO "All Comers" Post Market Clinical Follow-up (PMCF)

Role: lead

NCT02715466Phase 4Terminated

Gelatin in ICU and Sepsis

Role: lead

NCT03282955Phase 4Completed

The HOME Study (HPN With OMEGA-3)

Role: lead

NCT02495285Completed

Gelatines in Pediatric PatientS

Role: lead

NCT05124821Completed

Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed

Role: lead

NCT03332264Not ApplicableCompleted

Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions

Role: collaborator

NCT03278548Phase 4Completed

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery

Role: collaborator

NCT02197013Completed

Evaluation of Introcan Safety 3 Closed IV Catheter

Role: lead

NCT02147795Unknown

The German Patient Blood Management Network

Role: collaborator

NCT02914782Completed

Investigation of Fluid- and Electrolyte Balance in Post Cardiac-surgery Patients

Role: collaborator

NCT03338218Phase 4Completed

Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients

Role: collaborator

NCT02905214Completed

Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)

Role: lead

NCT04556318Completed

Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)

Role: lead

NCT04586998Not ApplicableWithdrawn

Comparison Between Propofol Concentration in Exhaled Breath and Blood Plasma Using the Exhaled Drug Monitor "Edmon"

Role: lead

NCT04649931Completed

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

Role: lead